Any patient considered as suffer CIDP should be considered as a possible POEMS syndrome patient if they are not responding to standard CIDP therapy, and additional testing should be done to rule in or rule out the diagnosis of POEMS (5). The gene discussed is PMP22; the disease is POEMS syndrome.